A controlled substance is generally a drug or chemical whose manufacture, possession, or use is regulated by a government, such as illicitly used drugs or prescription medications that are designated by law.
Market Analysis and Insights: Global Controlled Substances Market
The global Controlled Substances market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Drugs and other substances that are considered controlled substances under the Controlled Substances Act (CSA) are classified into five schedules. This scheduling is depended on the drug’s acceptable medical use and the drug’s abuse or dependency potential. The CSA scheduling list is annually updated and describes basic or parent chemical. This list is not comprehensive and does not describe salts, isomers, and salts of isomers, esters, ethers, and derivatives.
Report Covers:
This report presents an overview of global market for Controlled Substances market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Controlled Substances, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Controlled Substances, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Controlled Substances revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Controlled Substances market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Controlled Substances revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Johnson & Johnson
Pfizer
Siegfried AG
GlaxoSmithKline
Teva Pharmaceuticals
Viatris
Takeda Pharmaceutical
Sun Pharmaceutical
Daiichi Sankyo
Akorn Inc
Tilray
Medical Marijuana, Inc
Consort Medical
Purdue Pharma
Segment by Type
Opioids
Stimulants
Depressants
Marijuana
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Controlled Substances in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Controlled Substances companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Controlled Substances revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Controlled Substances Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Opioids
1.2.3 Stimulants
1.2.4 Depressants
1.2.5 Marijuana
1.2.6 Others
1.3 Market by Application
1.3.1 Global Controlled Substances Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Controlled Substances Market Perspective (2019-2030)
2.2 Global Controlled Substances Growth Trends by Region
2.2.1 Controlled Substances Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Controlled Substances Historic Market Size by Region (2019-2024)
2.2.3 Controlled Substances Forecasted Market Size by Region (2025-2030)
2.3 Controlled Substances Market Dynamics
2.3.1 Controlled Substances Industry Trends
2.3.2 Controlled Substances Market Drivers
2.3.3 Controlled Substances Market Challenges
2.3.4 Controlled Substances Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Controlled Substances by Players
3.1.1 Global Controlled Substances Revenue by Players (2019-2024)
3.1.2 Global Controlled Substances Revenue Market Share by Players (2019-2024)
3.2 Global Controlled Substances Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Controlled Substances, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Controlled Substances Market Concentration Ratio
3.4.1 Global Controlled Substances Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Controlled Substances Revenue in 2023
3.5 Global Key Players of Controlled Substances Head office and Area Served
3.6 Global Key Players of Controlled Substances, Product and Application
3.7 Global Key Players of Controlled Substances, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Controlled Substances Breakdown Data by Type
4.1 Global Controlled Substances Historic Market Size by Type (2019-2024)
4.2 Global Controlled Substances Forecasted Market Size by Type (2025-2030)
5 Controlled Substances Breakdown Data by Application
5.1 Global Controlled Substances Historic Market Size by Application (2019-2024)
5.2 Global Controlled Substances Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Controlled Substances Market Size (2019-2030)
6.2 North America Controlled Substances Market Size by Type
6.2.1 North America Controlled Substances Market Size by Type (2019-2024)
6.2.2 North America Controlled Substances Market Size by Type (2025-2030)
6.2.3 North America Controlled Substances Market Share by Type (2019-2030)
6.3 North America Controlled Substances Market Size by Application
6.3.1 North America Controlled Substances Market Size by Application (2019-2024)
6.3.2 North America Controlled Substances Market Size by Application (2025-2030)
6.3.3 North America Controlled Substances Market Share by Application (2019-2030)
6.4 North America Controlled Substances Market Size by Country
6.4.1 North America Controlled Substances Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Controlled Substances Market Size by Country (2019-2024)
6.4.3 North America Controlled Substances Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Controlled Substances Market Size (2019-2030)
7.2 Europe Controlled Substances Market Size by Type
7.2.1 Europe Controlled Substances Market Size by Type (2019-2024)
7.2.2 Europe Controlled Substances Market Size by Type (2025-2030)
7.2.3 Europe Controlled Substances Market Share by Type (2019-2030)
7.3 Europe Controlled Substances Market Size by Application
7.3.1 Europe Controlled Substances Market Size by Application (2019-2024)
7.3.2 Europe Controlled Substances Market Size by Application (2025-2030)
7.3.3 Europe Controlled Substances Market Share by Application (2019-2030)
7.4 Europe Controlled Substances Market Size by Country
7.4.1 Europe Controlled Substances Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Controlled Substances Market Size by Country (2019-2024)
7.4.3 Europe Controlled Substances Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Controlled Substances Market Size (2019-2030)
8.2 China Controlled Substances Market Size by Type
8.2.1 China Controlled Substances Market Size by Type (2019-2024)
8.2.2 China Controlled Substances Market Size by Type (2025-2030)
8.2.3 China Controlled Substances Market Share by Type (2019-2030)
8.3 China Controlled Substances Market Size by Application
8.3.1 China Controlled Substances Market Size by Application (2019-2024)
8.3.2 China Controlled Substances Market Size by Application (2025-2030)
8.3.3 China Controlled Substances Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Controlled Substances Market Size (2019-2030)
9.2 Asia Controlled Substances Market Size by Type
9.2.1 Asia Controlled Substances Market Size by Type (2019-2024)
9.2.2 Asia Controlled Substances Market Size by Type (2025-2030)
9.2.3 Asia Controlled Substances Market Share by Type (2019-2030)
9.3 Asia Controlled Substances Market Size by Application
9.3.1 Asia Controlled Substances Market Size by Application (2019-2024)
9.3.2 Asia Controlled Substances Market Size by Application (2025-2030)
9.3.3 Asia Controlled Substances Market Share by Application (2019-2030)
9.4 Asia Controlled Substances Market Size by Region
9.4.1 Asia Controlled Substances Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Controlled Substances Market Size by Region (2019-2024)
9.4.3 Asia Controlled Substances Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Controlled Substances Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Controlled Substances Market Size by Type
10.2.1 Middle East, Africa, and Latin America Controlled Substances Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Controlled Substances Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Controlled Substances Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Controlled Substances Market Size by Application
10.3.1 Middle East, Africa, and Latin America Controlled Substances Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Controlled Substances Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Controlled Substances Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Controlled Substances Market Size by Country
10.4.1 Middle East, Africa, and Latin America Controlled Substances Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Controlled Substances Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Controlled Substances Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Controlled Substances Introduction
11.1.4 Johnson & Johnson Revenue in Controlled Substances Business (2019-2024)
11.1.5 Johnson & Johnson Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Controlled Substances Introduction
11.2.4 Pfizer Revenue in Controlled Substances Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Siegfried AG
11.3.1 Siegfried AG Company Details
11.3.2 Siegfried AG Business Overview
11.3.3 Siegfried AG Controlled Substances Introduction
11.3.4 Siegfried AG Revenue in Controlled Substances Business (2019-2024)
11.3.5 Siegfried AG Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Controlled Substances Introduction
11.4.4 GlaxoSmithKline Revenue in Controlled Substances Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Controlled Substances Introduction
11.5.4 Teva Pharmaceuticals Revenue in Controlled Substances Business (2019-2024)
11.5.5 Teva Pharmaceuticals Recent Developments
11.6 Viatris
11.6.1 Viatris Company Details
11.6.2 Viatris Business Overview
11.6.3 Viatris Controlled Substances Introduction
11.6.4 Viatris Revenue in Controlled Substances Business (2019-2024)
11.6.5 Viatris Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Controlled Substances Introduction
11.7.4 Takeda Pharmaceutical Revenue in Controlled Substances Business (2019-2024)
11.7.5 Takeda Pharmaceutical Recent Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Controlled Substances Introduction
11.8.4 Sun Pharmaceutical Revenue in Controlled Substances Business (2019-2024)
11.8.5 Sun Pharmaceutical Recent Developments
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Controlled Substances Introduction
11.9.4 Daiichi Sankyo Revenue in Controlled Substances Business (2019-2024)
11.9.5 Daiichi Sankyo Recent Developments
11.10 Akorn Inc
11.10.1 Akorn Inc Company Details
11.10.2 Akorn Inc Business Overview
11.10.3 Akorn Inc Controlled Substances Introduction
11.10.4 Akorn Inc Revenue in Controlled Substances Business (2019-2024)
11.10.5 Akorn Inc Recent Developments
11.11 Tilray
11.11.1 Tilray Company Details
11.11.2 Tilray Business Overview
11.11.3 Tilray Controlled Substances Introduction
11.11.4 Tilray Revenue in Controlled Substances Business (2019-2024)
11.11.5 Tilray Recent Developments
11.12 Medical Marijuana, Inc
11.12.1 Medical Marijuana, Inc Company Details
11.12.2 Medical Marijuana, Inc Business Overview
11.12.3 Medical Marijuana, Inc Controlled Substances Introduction
11.12.4 Medical Marijuana, Inc Revenue in Controlled Substances Business (2019-2024)
11.12.5 Medical Marijuana, Inc Recent Developments
11.13 Consort Medical
11.13.1 Consort Medical Company Details
11.13.2 Consort Medical Business Overview
11.13.3 Consort Medical Controlled Substances Introduction
11.13.4 Consort Medical Revenue in Controlled Substances Business (2019-2024)
11.13.5 Consort Medical Recent Developments
11.14 Purdue Pharma
11.14.1 Purdue Pharma Company Details
11.14.2 Purdue Pharma Business Overview
11.14.3 Purdue Pharma Controlled Substances Introduction
11.14.4 Purdue Pharma Revenue in Controlled Substances Business (2019-2024)
11.14.5 Purdue Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Johnson & Johnson
Pfizer
Siegfried AG
GlaxoSmithKline
Teva Pharmaceuticals
Viatris
Takeda Pharmaceutical
Sun Pharmaceutical
Daiichi Sankyo
Akorn Inc
Tilray
Medical Marijuana, Inc
Consort Medical
Purdue Pharma
Ěý
Ěý
*If Applicable.
